Hester Biosciences has informed that the Company submitted a transcript of Earnings Conference Call held by the Management of the Company with investors on Friday, 7 February 2020 at 2.00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended on 31 December 2019.
The above information is a part of company’s filings submitted to BSE.